Table 2 Demographic and clinical characteristics of TB cases
All | Survived | Dieda | ||
|---|---|---|---|---|
Total | 653 | 628 | 25 (4.0) | |
Sex | Female | 293 | 286 | 7 (2.4) |
Male | 360 | 342 | 18 (5.0) | |
Age | < 65 years | 528 | 523 | 5 (1.0) |
≥ 65 years | 125 | 105 | 20 (16.0) | |
Country of birth | Australia | 18 | 18 | 0 (0.0) |
Overseas | 635 | 610 | 25 (4.1) | |
TB prevalence of COBb | Low | 192 | 182 | 10 (5.2) |
High | 461 | 446 | 15 (3.3) | |
Previous TB | No | 616 | 592 | 24 (3.9) |
Yes | 37 | 36 | 1 (2.7) | |
Site of disease | Pulmonary | 307 | 292 | 15 (4.9) |
Pulmonary plus other site/s | 102 | 96 | 6 (5.9) | |
Extra-pulmonary | 244 | 240 | 4 (1.6) | |
Culture-based diagnosis | No | 133 | 126 | 2 (1.5) |
Yes | 520 | 497 | 23 (4.4) | |
Drug resistancec | Pan-susceptible | 463 | 441 | 22 (4.8) |
Resistant to at least one drug, but not MDR-TB | 49 | 48 | 1 (2.0) | |
MDR-TB | 8 | 8 | 0 (0.0) | |
Renal impairment, eGFR | ≥ 60 ml/min | 602 | 592 | 10 (1.7) |
45–59 ml/min | 18 | 16 | 2 (11.1) | |
30–44 ml/min | 15 | 10 | 5 (33.3) | |
< 30 ml/min | 18 | 10 | 8 (44.4) | |
Diabetes status | No | 571 | 556 | 15 (2.6) |
Yes | 82 | 72 | 10 (12.2) |